BRCA2 and cancer: Women with a known family history of breast cancer, or of a predisposing gene mutation such as BRCA1 or BRCA2, have a cumulative lifetime risk of 45–65% (Antoniou et al, 2003), and a significant number of these cancers are diagnosed before the age of 50 years.